Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment

Eur J Dermatol. 2019 Feb 1;29(1):81-82. doi: 10.1684/ejd.2018.3434.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Antinuclear / blood*
  • Arthritis, Psoriatic / chemically induced*
  • Female
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Middle Aged
  • Psoriasis / drug therapy

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • Adalimumab